ACTIVE

DCV PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-226 k €

-320.3% YoY

Gross margin

70,7 k €

-63.6% YoY

Equity

1,3 M €

-14.8% YoY

What does DCV PHARMA do?

DCV PHARMA is a Private limited company incorporated in 2008. Its main activity is: Activities of holding companies. Its registered office is in Lier.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0807.314.964

Incorporation

14/10/2008

Legal form

Private limited company

Registered office

Botertonstraat 3 box 8
2500 Lier · FlandreSee on map

Contributed capital

6 200,00 €

Latest accounts

31/12/2025

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies 46450Wholesale of perfume and cosmetics 46450Wholesale of perfume and cosmetics 47750Retail sale of cosmetic and toilet articles in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores

Signals

Solid equityLow riskGood liquidityPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	70,7 k €	-63.6%	194,1 k €	-14.3%	226,6 k €	+3.6%	218,7 k €	-5.3%	231 k €	-5.7%	245 k €	-8.2%	267 k €	+9.9%	243,1 k €	-8.6%	266 k €	-26.0%	359,6 k €	-2.6%	369,2 k €	+1.1%	365,3 k €	+15.7%	315,8 k €	-15.9%	375,3 k €	+33.7%	280,7 k €	+2.6%	273,7 k €	+36.1%	201,1 k €
EBITDA	70,3 k €	-63.7%	193,8 k €	-14.3%	226,1 k €	+3.6%	218,3 k €	-5.3%	230,4 k €	-1.3%	233,5 k €	+13.8%	205,1 k €	+23.2%	166,5 k €	-15.1%	196 k €	-32.0%	288,2 k €	-4.8%	302,7 k €	+0.4%	301,4 k €	+24.7%	241,7 k €	-21.4%	307,4 k €	+39.7%	220,1 k €	-6.3%	234,8 k €	+16.9%	200,9 k €
Operating result	50 k €	-71.8%	177 k €	-15.4%	209,2 k €	+3.9%	201,3 k €	-5.5%	213,1 k €	-3.2%	220,1 k €	+17.6%	187,2 k €	+25.7%	148,9 k €	-15.6%	176,3 k €	-34.1%	267,5 k €	-5.2%	282,1 k €	+1.4%	278,2 k €	+27.5%	218,3 k €	-23.6%	285,7 k €	+55.1%	184,2 k €	-7.5%	199,1 k €	+0.1%	199 k €
Net result	-226 k €	-320%	102,6 k €	-15.1%	120,9 k €	+8.4%	111,5 k €	-3.6%	115,7 k €	-3.5%	119,9 k €	+33.7%	89,7 k €	+48.7%	60,3 k €	-10.7%	67,5 k €	-56.6%	155,7 k €	+6.6%	146,1 k €	-5.3%	154,4 k €	+51.0%	102,2 k €	-54.4%	224,3 k €	+274%	60 k €	-13.9%	69,7 k €	-14.5%	81,5 k €
Balance sheet
Equity	1,3 M €	-14.8%	1,5 M €	+4.3%	1,5 M €	+9.0%	1,3 M €	+9.0%	1,2 M €	+10.4%	1,1 M €	+12.0%	997,7 k €	+9.9%	908 k €	+7.1%	847,7 k €	+8.7%	780,1 k €	+12.3%	694,4 k €	+16.1%	598,3 k €	+18.7%	503,9 k €	+14.1%	441,7 k €	+103%	217,4 k €	+38.1%	157,4 k €	+79.4%	87,7 k €
Total assets	1,3 M €	-40.6%	2,3 M €	-0.7%	2,3 M €	+0.2%	2,3 M €	-0.8%	2,3 M €	-1.1%	2,3 M €	-0.6%	2,3 M €	-0.8%	2,3 M €	-2.9%	2,4 M €	+2.9%	2,3 M €	-2.5%	2,4 M €	-0.5%	2,4 M €	+0.3%	2,4 M €	-0.6%	2,4 M €	+11.7%	2,2 M €	-3.1%	2,2 M €	+19.6%	1,9 M €
Cash	933,1 k €	+2578%	34,8 k €	+543%	5,4 k €	-56.5%	12,5 k €	+244%	3,6 k €	-71.9%	12,9 k €	-28.1%	17,9 k €	-1.3%	18,2 k €	+24.2%	14,6 k €	+33.3%	11 k €	-47.6%	20,9 k €	-44.9%	38 k €	+78.6%	21,3 k €	+23.9%	17,2 k €	-80.5%	88,1 k €	+4.9%	84 k €	+47.4%	57 k €
Debts	32,6 k €	-95.5%	722,1 k €	-9.4%	796,7 k €	-12.9%	914,7 k €	-12.6%	1 M €	-11.9%	1,2 M €	-10.2%	1,3 M €	-7.5%	1,4 M €	-8.5%	1,6 M €	+0.2%	1,6 M €	-8.6%	1,7 M €	-5.9%	1,8 M €	-3.3%	1,9 M €	-1.9%	1,9 M €	-1.7%	1,9 M €	-6.2%	2,1 M €	+16.3%	1,8 M €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		1,8 ETP	0.0%	1,8 ETP	-14.3%	2,1 ETP	-16.0%	2,5 ETP	+31.6%	1,9 ETP	+11.8%	1,7 ETP		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Bram De Clercq

Director

Active

Ended mandates

Bram De Clercq

Manager

Ended

Karen Vervliet

Director

Ended

Karen Vervliet

Associate

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	16/06/2026	24/07/2025	12/07/2024	17/07/2023	14/07/2022	20/07/2021
General meeting	15/06/2026	16/06/2025	17/06/2024	19/06/2023	20/06/2022	21/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

17 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	15/06/2026	16/06/2026	Dutch	PDF
Abridged model	31/12/2024	16/06/2025	24/07/2025	Dutch	PDF
Micro model	31/12/2023	17/06/2024	12/07/2024	Dutch	PDF
Micro model	31/12/2022	19/06/2023	17/07/2023	Dutch	PDF
Micro model	31/12/2021	20/06/2022	14/07/2022	Dutch	PDF
Micro model	31/12/2020	21/06/2021	20/07/2021	Dutch	PDF
Micro model	31/12/2019	15/06/2020	13/07/2020	Dutch	PDF
Micro model	31/12/2018	17/06/2019	02/07/2019	Dutch	PDF
Micro model	31/12/2017	18/06/2018	09/07/2018	Dutch	PDF
Micro model	31/12/2016	19/06/2017	06/07/2017	Dutch	PDF
Abridged model	31/12/2015	20/06/2016	15/07/2016	Dutch	PDF
Abridged model	31/12/2014	15/06/2015	08/07/2015	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	22/07/2014	Dutch	PDF
Abridged model	31/12/2012	17/06/2013	28/06/2013	Dutch	PDF
Abridged model	31/12/2011	18/06/2012	10/07/2012	Dutch	PDF
Abridged model	31/12/2010	25/06/2011	20/07/2011	Dutch	PDF
Abridged model	31/12/2009	21/06/2010	19/07/2010	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Bram De Clercq

Director

Active

Ended mandates

Bram De Clercq

Manager

Ended

Karen Vervliet

Director

Ended

Karen Vervliet

Associate

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office30/03/2026
MAATSCHAPPELIJKE ZETEL
PDF
Mandates03/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Registered office03/05/2016
MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
PDF
Other05/05/2010
DOEL
PDF
Other31/10/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-226 k €↓
2024
Annual accounts 2024102,6 k €↓
2023
Annual accounts 2023120,9 k €↑
2022
Annual accounts 2022111,5 k €↓
2021
Annual accounts 2021115,7 k €↓
2020
Annual accounts 2020119,9 k €↑
2019
Annual accounts 201989,7 k €↑
2018
Annual accounts 201860,3 k €↓
2017
Annual accounts 201767,5 k €↓
2016
Annual accounts 2016155,7 k €↑
2015
Annual accounts 2015146,1 k €↓
2014
Annual accounts 2014154,4 k €↑
2013
Annual accounts 2013102,2 k €↓
2012
Annual accounts 2012224,3 k €↑
2011
Annual accounts 201160 k €↓
2010
Annual accounts 201069,7 k €↓
2009
Annual accounts 200981,5 k €
14/10/2008
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DCV PHARMA

Overview

What does DCV PHARMA do?

Trend over 17 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline